Drug class
Tetracycline-class antibacterial; 30S ribosomal subunit inhibitor
Mechanism of action
Reversibly binds the 30S ribosomal subunit and prevents aminoacyl-tRNA attachment to the ribosomal acceptor site, inhibiting bacterial protein synthesis and producing mainly bacteriostatic activity.
General use cases
- Treatment of infections caused by oxytetracycline-susceptible bacteria and selected atypical organisms where authorised; specific indications vary by oral, topical, ophthalmic and veterinary formulations and should follow local resistance guidance
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
